0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
RPG Life Sciences announces Q1 FY26 results: Revenue up 2.1% YoY to ₹168.9 Cr with 24.1% EBITDA margin. PBT stable at ₹35.4 Cr. Exploring inorganic growth for accelerated expansion.
Share this article
If you liked this article share it with your friends.they will thank you later
/smstreet/media/media_files/2025/07/26/rpg-life-sciences-2025-07-26-14-48-38.jpg)
1 Min read
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
